Top Story

FDA approves Zerbaxa for complicated intra-abdominal infections, UTIs

December 22, 2014

The FDA has approved a new combination antibiotic for the treatment of complicated intra-abdominal infections and complicated urinary tract infections in adults.

Ceftolozane/tazobactam (Zerbaxa, Cubist) contains a cephalosporin and a beta-lactamase inhibitor. Used alone, it can treat complicated UTIs, including pyelonephritis. It can also be used in combination with metronidazole to treat complicated intra-abdominal infections

In the Journals

PEG-IFN monotherapy reduced HBsAg expression

December 22, 2014
Patients with hepatitis B virus infection who underwent monotherapy with pegylated interferon had decreased hepatitis B surface antigen expression and an increased rate…

Mothers with probable, confirmed Ebola should not breast-feed

December 22, 2014
The Association of Women’s Health, Obstetric and Neonatal Nurses recently published recommendations for the management of pregnant women with Ebola.Patients with…
In the Journals

Influenza activity low but rising nationwide

December 22, 2014
From Sept. 28 to Dec. 6, almost 125,000 respiratory specimens in the United States were tested for influenza and 10.9% were positive, according to a CDC report…
In the Journals

Novel, cheap DNA sequencer identified S. typhi resistance

December 21, 2014
A novel nanopore DNA sequencer could rapidly diagnose infection at a greatly reduced price, according to recent data. Researchers tested the ability of the MinION…
More News Headlines »
CME
j64a_activity

CRITICAL ISSUES IN HBV: Considerations in Optimizing HBV Treatment

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
Meeting News Coverage Video
thumbnail for video 3911388507001

Student education, immunization requirements necessary to prevent outbreaks on college campuses

November 28, 2014
NEW YORK — James C. Turner, MD, executive director of the department of student health and the National Social…
More »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
morganatic-roan
morganatic-roan